HALF-LIFE OF ARYL-HYDROCARBON RECEPTOR IN HEPA-1 CELLS - EVIDENCE FOR LIGAND-DEPENDENT ALTERATIONS IN CYTOSOLIC RECEPTOR LEVELS

被引:43
作者
SWANSON, HI [1 ]
PERDEW, GH [1 ]
机构
[1] PURDUE UNIV,DEPT FOODS & NUTR,W LAFAYETTE,IN 47907
关键词
D O I
10.1006/abbi.1993.1195
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The rate of turnover of the Ah receptor (AhR) was determined using the density shift method in Hepa 1 and in a Hepa 1 mutant line, c4, which fails to accumulate AhR complexes in the nucleus. The half-life of the AhR was found to be 7.7 and 9.7 h in Hepa 1 and c4 cells, respectively. The effect of AhR occupation with either an agonist, β-naphthoflavone (βNF), or a partial antagonist, α-naphthoflavone (αNF), on AhR half-life and concentration in the cytosolic fraction was examined. In Hepa 1 cells, a 12-h exposure to βNF resulted in a 62% decrease in AhR concentration. The same treatment, using αNF as the ligand, resulted in a 14% decrease. The half-life of the AhR increased from 7.7 to 9.3 h during βNF treatment and was essentially the same during αNF treatment in Hepa 1 cells. In c4 cells, a 12-h exposure to βNF resulted in a 44% decrease in AhR concentrations, whereas exposure to αNF resulted in an 8% decrease. The half-life of the AhR in c4 cells during βNF exposure increased from 9.7 to 14.6 h, and αNF exposure increased half-life to 17.6 h. These results indicate: (a) cytosolic AhR concentrations are modulated by ligand occupation, (b) exposure to AhR ligands, after an initial decrease in AhR levels, resulted in an increase in AhR half-life, and (c) similar results were obtained in Hepa 1 and c4 cells, this would indicate that AhR occupation with ligand and subsequent AhR-ligand nuclear translocation does not appear to play a significant role in regulation of AhR half-life in Hepa 1 cells. © 1993 Academic Press. All rights reserved.
引用
收藏
页码:167 / 174
页数:8
相关论文
共 37 条
[1]  
BLANK JA, 1987, MOL PHARMACOL, V32, P168
[2]  
BRADFIELD CA, 1988, MOL PHARMACOL, V34, P229
[3]  
CUTHILL S, 1987, J BIOL CHEM, V262, P3477
[4]   ASSOCIATION OF THE DIOXIN RECEPTOR WITH THE MR 90,000 HEAT-SHOCK PROTEIN - A STRUCTURAL KINSHIP WITH THE GLUCOCORTICOID RECEPTOR [J].
DENIS, M ;
CUTHILL, S ;
WIKSTROM, AC ;
POELLINGER, L ;
GUSTAFSSON, JA .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1988, 155 (02) :801-807
[5]  
DENISON MS, 1990, ARCH BIOCHEM BIOPHYS, V311, P382
[6]   EVIDENCE FROM PULSE-CHASE LABELING STUDIES THAT THE ANTIGLUCOCORTICOID HORMONE-RU486 STABILIZES THE NONACTIVATED FORM OF THE GLUCOCORTICOID RECEPTOR IN MOUSE LYMPHOMA-CELLS [J].
DISTELHORST, CW ;
HOWARD, KJ .
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1990, 36 (1-2) :25-31
[7]   ESTROGEN-RECEPTOR SYNTHESIS AND TURNOVER IN MCF-7 BREAST-CANCER CELLS MEASURED BY A DENSITY SHIFT TECHNIQUE [J].
ECKERT, RL ;
MULLICK, A ;
RORKE, EA ;
KATZENELLENBOGEN, BS .
ENDOCRINOLOGY, 1984, 114 (02) :629-637
[8]  
ECKERT RL, 1982, CANCER RES, V42, P139
[9]   CDNA CLONING AND STRUCTURE OF MOUSE PUTATIVE AH RECEPTOR [J].
EMA, M ;
SOGAWA, K ;
WATANABE, N ;
CHUJOH, Y ;
MATSUSHITA, N ;
GOTOH, O ;
FUNAE, Y ;
FUJIIKURIYAMA, Y .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1992, 184 (01) :246-253
[10]   CHARACTERIZATION OF MULTIPLE FORMS OF THE AH RECEPTOR - RECOGNITION OF A DIOXIN-RESPONSIVE ENHANCER INVOLVES HETEROMER FORMATION [J].
GASIEWICZ, TA ;
ELFERINK, CJ ;
HENRY, EC .
BIOCHEMISTRY, 1991, 30 (11) :2909-2916